Suppr超能文献

人参保健作用的系统评价:韩国文献中随机对照试验的研究

Ginseng for health care: a systematic review of randomized controlled trials in Korean literature.

机构信息

Medical Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.

出版信息

PLoS One. 2013;8(4):e59978. doi: 10.1371/journal.pone.0059978. Epub 2013 Apr 1.

Abstract

OBJECTIVE

This systematic review was performed to summarise randomised clinical trials (RCTs) assessing the efficacy and safety of ginseng in the Korean literature.

METHOD

The study involved systematic searches conducted in eight Korean Medical databases. The methodological quality of all of the included studies was assessed using the Cochrane Risk of Bias tool. We included all RCTs on any type of ginseng compared to placebo, active treatment or no treatment in healthy individuals or patients regardless of conditions.

RESULTS

In total, 1415 potentially relevant studies were identified, and 30 randomised clinical trials were included. Nine RCTs assessed the effects of ginseng on exercise capacity, cognitive performance, somatic symptoms, quality of life, and sleeping in healthy persons. Six RCTs tested ginseng compared with placebo for erectile dysfunction, while another four studies evaluated the effects of ginseng against no treatment for gastric and colon cancer. Two RCTs compared the effect of red ginseng on diabetes mellitus with no treatment or placebo, and the other nine RCTs assessed the effects of ginseng compared with placebo or no treatment on various conditions. The methodological caveats of the included trials make their contribution to the current clinical evidence of ginseng somewhat limited. However, the 20 newly added trials (66.7% of the 30 trials) may provide useful information for future trials. Ginseng appears to be generally safe, and no serious adverse effects have been reported.

CONCLUSIONS

The clinical effects of ginseng have been tested in a wide range of conditions in Korea. Although the quality of RCTs published in the Korean literature was generally poor, this review is useful for researchers to access studies that were originally published in languages that they would otherwise be unable to read and due to the paucity of evidence on this subject.

摘要

目的

本系统评价旨在总结评估人参在韩国文献中的疗效和安全性的随机临床试验(RCT)。

方法

研究中在 8 个韩国医学数据库中进行了系统检索。使用 Cochrane 偏倚风险工具评估所有纳入研究的方法学质量。我们纳入了所有类型的人参与安慰剂、阳性对照或健康人群或患者无论疾病状况的无治疗相比的 RCT。

结果

共确定了 1415 篇潜在相关研究,纳入了 30 项随机临床试验。9 项 RCT 评估了人参对健康人群的运动能力、认知表现、躯体症状、生活质量和睡眠的影响。6 项 RCT 测试了人参对勃起功能障碍的作用,而另外 4 项研究评估了人参对胃癌和结肠癌无治疗的效果。2 项 RCT 比较了红参对糖尿病的影响与无治疗或安慰剂,另外 9 项 RCT 评估了人参与安慰剂或无治疗对各种疾病的影响。纳入试验的方法学缺陷使得它们对当前人参临床证据的贡献有些有限。然而,20 项新加入的试验(30 项试验中的 66.7%)可能为未来的试验提供有用的信息。人参似乎通常是安全的,没有报告严重的不良反应。

结论

人参在韩国的多种情况下进行了临床效果的测试。尽管韩国文献中发表的 RCT 质量普遍较差,但由于本综述可以帮助研究人员获取原本无法阅读的语言发表的研究,以及由于该主题证据不足,因此对研究人员很有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83d/3613407/c3cbfdfd8ded/pone.0059978.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验